You are here


A vaccine that can literally eradicate the majority of cervical cancer cases shows long-term effectiveness in a study published today in The Lancet. This study of 14,215 women in 18 countries extends and solidifies the initial phase 3 efficacy and safety trial of the nine-valent human papilloma virus vaccine, Gardasil 9, that was published in February 2015 in The New England Journal of Medicine.

These new results strengthen the promise that vaccination with Gardasil 9 can reduce 90 percent of cervical cancers.

A new meta-analysis shows that pregnant women with endometriosis are at greater risk for a host of complications during pregnancy and at delivery, including preterm birth and cesarean section. The study was published in the journal Fertility and Sterility.

Fewer women are getting hysterectomies in every state across the country.

Instead, more patients may be choosing minimally invasive procedures or other alternatives to handle issues like pelvic pain and fibroids over a traditional abdominal hysterectomy, new Michigan Medicine research suggests.

The American Cancer Society state that cervical cancer used to be the leading cause of cancer death for women in the US. But because more women are undergoing screening for the disease, the number of deaths from the condition have decreased significantly over the past 40 years.

Cervical cancer is most common in women between the ages of 21-50.

If you're a woman, you may view the Pap test as somewhat of an inconvenience, or even a few minutes of terror. This might put you off from getting tested, but here's why you should stop avoiding it and book an appointment now.

Have you checked that Pap smear off your list, or are you still putting it off?

As January is Cervical Health Awareness Month, we figured it was high time to talk about the test that adult women are scared to go ahead with: the Pap test. What is it, and why is it important?

Considered a safe and highly effective contraception method, intrauterine devices (IUDs) may also be quietly offering protection against the third-most common cancer in women worldwide. A new study from the Keck School of Medicine of USC has found that IUD use is associated with a dramatic decrease in the incidence of cervical cancer.

A decade of data on hundreds of boys and girls who received the HPV vaccine indicates the vaccine is safe and effective long term in protecting against the most virulent strains of the virus, researchers report.

The findings support more widespread and early administration of the HPV vaccine before preadolescents and adolescents are exposed to the nation's most common sexually transmitted infection and the most common cause of cervical cancer, they report in the journal Pediatrics.

Gynecologic cancers affect any area of the female reproductive organs (uterus, cervix, ovaries, vulva). For 2017, the American Cancer Society estimates more than 100,000 new cases of gynecologic cancer and more than 31,000 deaths. Luckily these organs are either visible or can give early symptoms of pre-cancer and cancer.

As the number of women in the military increases, so does the need for improved gynecologic care. Military women may be more likely to engage in high-risk sexual practices, be less likely to consistently use barrier contraception, and, therefore, more likely to contract sexually transmitted infections (STIs), according to research recently released by a physician at Women & Infants Hospital of Rhode Island.

Cervical cancer affects more than half a million women and causes more than a quarter of a million deaths each year globally. Almost all cervical cancers result from a human papillomavirus, or HPV, infection. HPV infections cause cancers in other parts of the body, too. But the latest HPV vaccine could prevent most infections -; and millions of cancers -; worldwide, according to an article by Cosette Wheeler, PhD, and her collaborators.


Subscribe to Gynecology